James A. Bianco

Founder at CTI BioPharma Corp.

James A. Bianco

James A. Bianco

Founder at CTI BioPharma Corp.

Overview
Career Highlights

CTI BioPharma Corp.
Aequus BioPharma, Inc.

RelSci Relationships

432

Number of Boards

11

Birthday

1957

Age

62

Relationships
RelSci Relationships are individuals James A. Bianco likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Aequus BioPharma, Inc.

Relationship likelihood: Strong

President at Seattle Symphony Foundation

Relationship likelihood: Strong

Chief Financial Officer at DigiPen Institute of Technology

Relationship likelihood: Strong

Former Director of Planning, US Pharmaceuticals at Pfizer, Inc.

Relationship likelihood: Strong

Managing Director at Ascalon Pharmaceuticals

Relationship likelihood: Strong

President, Chief Executive Officer & Director at KitoTech Medical, Inc.

Relationship likelihood: Strong

Board Member at 5th Avenue Theatre Association

Relationship likelihood: Strong

President at Friends of Jose Carreras International Leukemia Foundation

Relationship likelihood: Strong

Transplant Biologist & Mentor at Fred Hutchinson Cancer Research Center

Relationship likelihood: Strong

Chief Financial Officer, Secretary & Executive Vice President at CTI BioPharma Corp.

Relationship likelihood: Strong

Paths to James A. Bianco
Potential Connections via
Relationship Science
You
James A. Bianco
Founder at CTI BioPharma Corp.
Education
BS Biology & Physics

Founded in 1831, New York University is now one of the largest private universities in the United States. Of the more than 3,000 colleges and universities in America, New York University is one of only 60 member institutions of the distinguished Association of American Universities. From a student body of 158 during NYU's very first semester, enrollment has grown to more than 40,000 students attending 18 schools and colleges at five major centers in Manhattan and in sites in Africa, Asia, Europe, and South America. Today, students come from every state in the union and from 133 foreign countries. The faculty, which initially consisted of fourteen professors and lecturers (among them artist and inventor Samuel F. B. Morse), now totals over 3,100 full-time members whose research and teaching encompasses the humanities, the sciences, and the social sciences; the law; medicine; business; education; the fine arts, studio art, and the performing and cinematic arts; music; social work; public administration; the ancient world; and continuing and professional studies. With more than 2,500 courses offered, the University awards more than 25 different degrees. Although overall the University is large, the individuals schools and colleges are small- to moderate-sized units—each with its own traditions, programs, and faculty – and there are many communities to be found within the NYU community based on interests, activities, and shared experiences. The center of NYU is its Washington Square campus in the heart of Greenwich Village. One of the city's most creative and energetic communities, the Village is a historic neighborhood that has attracted generations of writers, musicians, artists, and intellectuals. NYU, in keeping with its founder’s vision, is “in and of the city”: the University – which has no walls and no gates – is deeply intertwined with New York City, drawing inspiration from its vitality. In addition to its Manhattan locations, the University is also formally affiliated the Polytechnic Institute of NYU in Brooklyn, the second oldest school of engineering and technology in the country, and has research facilities, notably the Nelson Institute of Environmental Medicine, in Sterling Forest, near Tuxedo, New York. And NYU has established itself as the first global network university, with a comprehensive liberal arts campus in Abu Dhabi – the first to be operated abroad by a major U.S. research university – and other sites for study and research in Accra, Ghana; Berlin, Germany; Buenos Aires, Argentina; Florence, Italy; London, England; Madrid, Spain; Paris, France; Prague, the Czech Republic; Shanghai, China; and Tel Aviv, Israel, among other locations.

MD

The School commits to dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

Graduate

The University of Washington School of Medicine (UWSOM) is a public medical school in the northwest United States, located in Seattle and affiliated with the University of Washington.

Career History
Director-Bone Marrow Transplant Program
Prior

Veterans Administration Medical Center is an American private company located in San Diego, CA. The firm provides healthcare services.

Founder
Prior - 2016

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Principal Founder
Prior

Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals.Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars.

Boards & Committees
Non-Executive Chairman
Current

Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals.Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars.

Director
Current
Director
1992 - 2017

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Director
Current

TO AID AND SUPPORT THE SEATTLE SYMPHONY ORCHESTRA.

Director
Current

SEATTLE POLICE FOUNDATION RAISES SUPPORT AND AWARENESS FOR THE SEATTLE POLICE DEPARTMENT (SPD).

Director
Current
Political Donations
$250
2012

Senator at Office of the Senator from Utah, Mitt Romney

$1,000
2001

Former Senator from Iowa

$1,000
2000

Former Senator from Iowa

Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James A. Bianco. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James A. Bianco's profile does not indicate a business or promotional relationship of any kind between RelSci and James A. Bianco.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/james-a-bianco-3233492
  • https://relationshipscience.com/person/james-a-bianco-3233492